The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AC1MIWZV     (4S,7S,10S,16S,19S)-19-amino- 10-(2...

Synonyms: 35748-51-7, Pressinoic acid
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on Pressinoic acid

 

Biological context of Pressinoic acid

  • Oxytocin, vasopressin, and AVP4-9 inhibited activity in tadpoles while mesotocin, des Gly(NH2)AVP, and pressinoic acid had no significant effect [4].
  • Even though cyclic peptides were obtained very rapidly and in good yields when cyclization was performed in aqueous media at different pHs (4 to 7), the final crude peptides were found to contain closely related impurities which, in the case of somatostatin and pressinoic acid, were not generated by air oxidation [5].
 

Anatomical context of Pressinoic acid

  • The V2 agonist 1-desamino-8-D-AVP and pressinoic acid produced weak inhibitions only in guinea pig choroid plexus, and Ki/Km ratios indicated 220 and 310 times lower affinities than for AVP, respectively [6].
 

Associations of Pressinoic acid with other chemical compounds

  • Conformations of OT and AVP with a turn at residues 3,4 were in the best agreement with the x-ray structures of deaminooxytocin and pressinoic acid (the cyclic moiety of vasopressin), respectively, and with the nmr-derived distance constraints [7].
  • Influx of VP into the brain was not altered by the presence of the peptide fragments: VP-(1-8), pressinoic acid and [pGlu4,Cyt6]VP-(4-9) at 4.5 microM, nor yet by the aminopeptidase inhibitor, bestatin (0.5 mM) and the L-amino acid transport system substrates, L-tyrosine and L-phenylalanine at 5 mM [8].

References

  1. Structure of pressinoic acid: the cyclic moiety of vasopressin. Langs, D.A., Smith, G.D., Stezowski, J.J., Hughes, R.E. Science (1986) [Pubmed]
  2. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes. Torres, B.A., Johnson, H.M. J. Immunol. (1988) [Pubmed]
  3. A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function. Johnson, H.M., Torres, B.A. J. Immunol. (1988) [Pubmed]
  4. Effect of vasotocin on locomotor activity in bullfrogs varies with developmental stage and sex. Boyd, S.K. Hormones and behavior. (1991) [Pubmed]
  5. Use of carboethoxysulfenyl chloride for disulfide bond formation. Le-Nguyen, D., Rivier, J. Int. J. Pept. Protein Res. (1986) [Pubmed]
  6. Kinetics of circulating vasopressin uptake by choroid plexus. Zlokovic, B.V., Segal, M.B., McComb, J.G., Hyman, S., Weiss, M.H., Davson, H. Am. J. Physiol. (1991) [Pubmed]
  7. Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods. Liwo, A., Tempczyk, A., Ołdziej, S., Shenderovich, M.D., Hruby, V.J., Talluri, S., Ciarkowski, J., Kasprzykowski, F., Lankiewicz, L., Grzonka, Z. Biopolymers (1996) [Pubmed]
  8. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Zlokovic, B.V., Hyman, S., McComb, J.G., Lipovac, M.N., Tang, G., Davson, H. Biochim. Biophys. Acta (1990) [Pubmed]
 
WikiGenes - Universities